CDKN2B-AS1 and nasopharyngeal carcinoma: In addition, inhibition of SOX2 by shRNA strongly inhibits ANRIL expression, indicating that SOX2 and ANRIL are required for nasopharyngeal carcinoma proliferation and tumourigenesis.